Reduction in Pricing Grid Lowers Cost of CapitalMaximum Facility Size Increased from $750 million to $1.5 billion FORT WORTH, Texas, Dec. 16, 2025 /PRNewswire/ -- Kimbell Royalty Partners, LP (NYSE: KRP) ("Kimbell" or the "Company"), a leading owner of oil and natural gas mineral and royalty interests in over 131,000 gross wells across 28 states, today announced the successful completion of its scheduled Fall 2025 redetermination and concurrent amendment and restatement of its secured revolving credit faci ...

Core Viewpoint - Accuray Incorporated has entered into agreements to exchange $82 million of its senior convertible notes for shares of common stock and cash, enhancing its capital structure and liquidity [1][8]. Financing Agreements - The company has secured a new senior secured credit agreement providing for $150 million in term loan facilities, a $20 million delayed draw term loan facility, and a $20 million revolving credit facility [3]. - Proceeds from these facilities, along with available cash, will be used to repay all outstanding indebtedness under a previous credit agreement with Silicon Valley Bank [3]. Interest Rates and Terms - Interest on borrowings under the new facilities can be based on either a term SOFR-based rate with a 2.00% floor plus an 8.50% margin, or a base rate with a 3.00% floor plus a 7.50% margin [4]. Governance Changes - A governance agreement has been established with TCW, allowing for the appointment of one director and two non-voting board observers to Accuray's Board [6]. - Steven F. Mayer has been appointed to the Board, bringing extensive governance experience from various industries [7][8]. Warrants Issuance - Accuray has issued warrants to lenders, including 17,180,710 Premium Warrants with an exercise price of $1.68 per share and 6,247,531 Penny Warrants with an exercise price of $0.01 per share [8][9]. - Additional warrants will be issued upon drawing from the delayed draw term loan, with specific terms for exercise prices and anti-dilution protections [10][11]. Strategic Priorities - The company aims to transform radiation therapy care and create long-term shareholder value, supported by the new financing agreement [8].